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Abstract
Identification and exploration of antibacterial and antibiofilm compounds against different structural targets of Streptococcus pyogenes through in silico and in vitro approaches.
S. pyogenes is a human pathogen capable of causing pharyngitis and strep-throat related infections. Owing to the upsurge of multidrug resistance in S. pyogenes, there is a considerable interest in understanding the pathogenicity of the organism. The first initiative step was to identify proteins that have essential role during survival and regulation of virulence factors in S. pyogenes. The second step is to screen potential antimicrobial compounds against these targets. Due to increased advancement in pharmaceutical sciences, which are yet to be fully explored for therapeutic usage against bacterial pathogens, a large dataset of compounds are available in the public domains. Antibiotics play a crucial part to combat with infectious diseases. Numerous antimicrobial targets are described in the near past to identify lead molecules. In the current study, targets from S. pyogenes that are unexplored are classified into antibacterial and antibiofilm targets. Targets such as SPFabG, SPGyrA, SPGtfs, SPLuxS playing a significant role during survival and pathogenicity of S. pyogenes have been delineated. Screening of the compounds available in the public domains against these targets has culminated in the identification of few potential lead molecules. Therefore, from the in vitro studies, it was confirmed that, these compounds can combat resistance and when fully explored can be used as therapeutic against S. pyogenes related infections. In the current scenario, a user has to necessarily visit all data resources related to the problem in order to get the relevant information. SPEIDS, an annotation database finds utility in the scientific community for a quick view of the collection of data for the inhibitors classified based on various sources and pharmacological actions. Developing database and making it publicly accessible enables a large number of scientists/clinicians to perform further investigation on the drugs essential for their field of research. This classification in SPEIDS will assist the scientific users to choose the ligands for their studies related to S. pyogenes infections.

